Monocyte Recruitment in Venous Pulmonary Embolism at Time of Cancer Diagnosis in Upper Gastrointestinal Cancer Patients

Overview

Journal J Thromb Thrombolysis

Specialty Cardiology & Vascular Diseases

Date 2023 Oct 4

PMID 37792208

Authors

Sarah S Jakobsen

Jens B Frokjaer

Rune V Fisker

Soren R Kristensen

Ole Thorlacius-Ussing

Anders C Larsen

Affiliations

Soon will be listed here.

Abstract

Upper gastrointestinal cancer is frequently complicated by venous thromboembolisms (VTE), especially pulmonary embolisms (PE) increase the mortality rate. Monocytes are a part of the innate immune system and up-regulation may indicate an ongoing inflammatory response or infectious disease and has lately been associated with a moderate risk of suffering from VTE. This prospectively study aims to compare the incidence of pulmonary embolism with markers of coagulation and compare it to the absolute monocyte count. A consecutive cohort of 250 patients with biopsy proven upper gastrointestinal cancer (i.e. pancreas, biliary tract, esophagus and gastric cancer) where included at the time of cancer diagnosis and before treatment. All patients underwent bilateral compression ultrasonography for detection of deep vein thrombosis (DVT). Of these 143 had an additionally pulmonary angiografi (CTPA) with the staging computer tomography. 13 of 250 patients (5.2%) had a DVT and 11 of 143 (7.7%) had CTPA proven PE. PE was significantly more common among patients with elevated D-dimer (OR 11.62, 95%CI: 1.13-119, P = 0.039) and elevated absolute monocyte count (OR 7.59, 95%CI: 1.37-41.98, P = 0.020). Only patients with pancreatic cancer had a significantly higher risk of DVT (OR 11.03, 95%CI: 1.25-97.43, P = 0.031). The sensitivity of absolute monocyte count was 63.6 (95%CI: 30.8-89.1) and specificity 80.3 (95%CI: 72.5-86.7), with a negative predictive value of 96.4 (95%CI: 91-99) in PE. An increased absolute monocyte count was detected in patients suffering from PE but not DVT, suggesting a possible interaction with the innate immune system.

References

Hanna R, Cekic C, Sag D, Tacke R, Thomas G, Nowyhed H . Patrolling monocytes control tumor metastasis to the lung. Science. 2015; 350(6263):985-90. PMC: 4869713. DOI: 10.1126/science.aac9407. View

Larsen A, Frokjaer J, Fisker R, Iyer V, Mortensen P, Yilmaz M . Treatment-related frequency of venous thrombosis in lower esophageal, gastro-esophageal and gastric cancer--a clinical prospective study of outcome and prognostic factors. Thromb Res. 2015; 135(5):802-8. DOI: 10.1016/j.thromres.2015.01.021. View

den Exter P, Hooijer J, Dekkers O, Huisman M . Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients. J Clin Oncol. 2011; 29(17):2405-9. DOI: 10.1200/JCO.2010.34.0984. View

Khorana A, Kuderer N, McCrae K, Milentijevic D, Germain G, Laliberte F . Cancer associated thrombosis and mortality in patients with cancer stratified by khorana score risk levels. Cancer Med. 2020; 9(21):8062-8073. PMC: 7643641. DOI: 10.1002/cam4.3437. View

Yu Y, Malakhau Y, Yu C, Phelan S, Cumming R, Kan M . Nonclassical Monocytes Sense Hypoxia, Regulate Pulmonary Vascular Remodeling, and Promote Pulmonary Hypertension. J Immunol. 2020; 204(6):1474-1485. PMC: 7065976. DOI: 10.4049/jimmunol.1900239. View

Kearon C, Ginsberg J, Douketis J, Turpie A, Bates S, Lee A . An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trial. Ann Intern Med. 2006; 144(11):812-21. DOI: 10.7326/0003-4819-144-11-200606060-00007. View

Wang Z, Zhou Q, Liu H, Zhang J, Zhu Z, Wu J . Association Between Monocyte Count and Preoperative Deep Venous Thrombosis in Older Patients with hip Fracture: A Retrospective Study. Clin Appl Thromb Hemost. 2022; 28:10760296221100806. PMC: 9102124. DOI: 10.1177/10760296221100806. View

Gibson N, Sohne M, Kruip M, Tick L, Gerdes V, Bossuyt P . Further validation and simplification of the Wells clinical decision rule in pulmonary embolism. Thromb Haemost. 2008; 99(1):229-34. DOI: 10.1160/TH07-05-0321. View

Khorana A, Barnard J, Wun T, Vijapurkar U, Damaraju C, Moore K . Biomarker signatures in cancer patients with and without venous thromboembolism events: a substudy of CASSINI. Blood Adv. 2021; 6(4):1212-1221. PMC: 8864658. DOI: 10.1182/bloodadvances.2021005710. View

10.

Stein P, Henry J . Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest. 1995; 108(4):978-81. DOI: 10.1378/chest.108.4.978. View

11.

Rezende S, Lijfering W, Rosendaal F, Cannegieter S . Hematologic variables and venous thrombosis: red cell distribution width and blood monocyte count are associated with an increased risk. Haematologica. 2013; 99(1):194-200. PMC: 4007947. DOI: 10.3324/haematol.2013.083840. View

12.

Colling M, Tourdot B, Kanthi Y . Inflammation, Infection and Venous Thromboembolism. Circ Res. 2021; 128(12):2017-2036. PMC: 8202069. DOI: 10.1161/CIRCRESAHA.121.318225. View

13.

Stein P, Matta F, Musani M, Diaczok B . Silent pulmonary embolism in patients with deep venous thrombosis: a systematic review. Am J Med. 2010; 123(5):426-31. DOI: 10.1016/j.amjmed.2009.09.037. View

14.

Blom J, Vanderschoot J, Oostindier M, Osanto S, van der Meer F, Rosendaal F . Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost. 2006; 4(3):529-35. DOI: 10.1111/j.1538-7836.2006.01804.x. View

15.

von Bruhl M, Stark K, Steinhart A, Chandraratne S, Konrad I, Lorenz M . Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med. 2012; 209(4):819-35. PMC: 3328366. DOI: 10.1084/jem.20112322. View

16.

Stark K, Massberg S . Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol. 2021; 18(9):666-682. PMC: 8100938. DOI: 10.1038/s41569-021-00552-1. View

17.

Shahneh F, Probst H, Wiesmann S, A-Gonzalez N, Ruf W, Steinbrink K . Inflammatory Monocyte Counts Determine Venous Blood Clot Formation and Resolution. Arterioscler Thromb Vasc Biol. 2021; 42(2):145-155. DOI: 10.1161/ATVBAHA.121.317176. View

18.

Brooks E, Trotman W, Wadsworth M, Taatjes D, Evans M, Ittleman F . Valves of the deep venous system: an overlooked risk factor. Blood. 2009; 114(6):1276-9. PMC: 2723019. DOI: 10.1182/blood-2009-03-209981. View

19.

Tagalakis V, Patenaude V, Kahn S, Suissa S . Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. Am J Med. 2013; 126(9):832.e13-21. DOI: 10.1016/j.amjmed.2013.02.024. View

20.

Oto J, Navarro S, Larsen A, Solmoirago M, Plana E, Hervas D . MicroRNAs and Neutrophil Activation Markers Predict Venous Thrombosis in Pancreatic Ductal Adenocarcinoma and Distal Extrahepatic Cholangiocarcinoma. Int J Mol Sci. 2020; 21(3). PMC: 7043221. DOI: 10.3390/ijms21030840. View